EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Pyrrolopyrimidine Based Dual Heterocyclic Hybrids as Antiproliferative Agents: Synthesis, In-vitro Assessment, Docking, and ADME Exploration

Nagaraju Madala, Vishal Sharma, Srilalitha Vinnakota

Journal of Advanced Chemical Sciences · 16.07.2026 · 12 (5) · 1037

DOI: 10.30799/jacs.281.26120503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Advanced Chemical Sciences, online erschienen am 16.07.2026. Verfasst von Nagaraju Madala und 2 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present work reports the synthesis of novel pyrrolo[2,3-d]pyrimidine and 1,3,4–oxadiazole hybrids bearing 1,2,3–triazole substituents, efficiently obtained via CuAAC click reactions. The results indicated that 1,2,3–triazole hybrids 5b and 5g demonstrated the highest cytotoxicity against A-549 and HCT-116 cells with IC50 values of 6.12±1.15 µM and 8.01±1.72 µM and 5.20±0.99 µM and 6.60±1.90 µM, respectively, compared with the reference drug doxorubicin (5.40±1.75 µM for A-549 and 6.60±1.23 µM for HCT-116). Molecular docking revealed the structural basis for this activity, showing compounds 5b, 5e and 5g strong binding to key target like EGFR mutant in lung cancer pocket of (PDB code: 8d76) via binding affinities ranging from −7.49 to −7.79 kcal/mol. The in-silico ADME/Tox analysis confirmed the drug-likeness of all the prepared compounds, indicating their potential for oral bioavailability and overall therapeutic efficacy. Collectively, these properties distinguish 5b, 5e and 5g, positioning it as the most potent and selective anticancer lead.

Zitieren

APA

Madala, N., Sharma, V., & Vinnakota, S. (2026). Novel Pyrrolopyrimidine Based Dual Heterocyclic Hybrids as Antiproliferative Agents: Synthesis, In-vitro Assessment, Docking, and ADME Exploration. Journal of Advanced Chemical Sciences, 12(5), 1037. https://doi.org/10.30799/jacs.281.26120503

Vancouver

Madala N, Sharma V, Vinnakota S. Novel Pyrrolopyrimidine Based Dual Heterocyclic Hybrids as Antiproliferative Agents: Synthesis, In-vitro Assessment, Docking, and ADME Exploration. Journal of Advanced Chemical Sciences. 2026;12(5):1037. doi:10.30799/jacs.281.26120503

BibTeX
@article{Madala2026,
  author = {Madala, Nagaraju and Sharma, Vishal and Vinnakota, Srilalitha},
  title = {Novel Pyrrolopyrimidine Based Dual Heterocyclic Hybrids as Antiproliferative Agents: Synthesis, In-vitro Assessment, Docking, and ADME Exploration},
  journal = {Journal of Advanced Chemical Sciences},
  year = {2026},
  volume = {12},
  number = {5},
  pages = {1037},
  doi = {10.30799/jacs.281.26120503}
}
Kostenlos starten →